New Type of Stem Cell Could Make It Easier to Grow Human Organs

The “region-specific” pluripotent cells are easier to grow in vitro and graft into an embryo when injected into the right spot

Join Our Community of Science Lovers!

A newly discovered type of stem cell could help provide a model for early human development—and, eventually, allow human organs to be grown in large animals such as pigs or cows for research or therapeutic purposes.

Juan Carlos Izpisua Belmonte, a developmental biologist at the Salk Institute for Biological Studies in La Jolla, California, and his colleagues stumbled across a previously unknown variety of pluripotent cell—which can give rise to any type of tissue—while attempting to graft human pluripotent stem cells into mouse embryos. 

Scientists previously knew about two other types of pluripotent stem cells, but growing them in large numbers or guiding them to mature into specific types of adult cells has proven difficult. Writing in Nature, Izpisua Belmonte and his colleagues report a type of pluripotent cell that is easier to grow in vitro and grafts into an embryo when injected into the right spot. They call them region-selective pluripotent stem cells (rsPSCs).


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Because the region-selective cells grow more quickly and stably than other pluripotent cells, they may be more useful for developing new therapies, says Paul Tesar, a developmental biologist at Case Western Reserve University in Cleveland, Ohio.

Micro brew
Izpisua Belmonte and colleagues sought to transplant known types of human pluripotent cell into mouse embryos in vitro. They prepared these cells by growing them in media containing different combinations of growth factors and chemicals. One blend was more effective at making the cells grow and proliferate. The cells that thrived in this solution were found to display different patterns of metabolism and gene expression from other pluripotent stem cells—but they did not graft well into the mouse embryo.

To pinpoint the factors that could be holding back this integration, the researchers injected the human cells into three different regions of a 7.5-day-old mouse embryo. Thirty-six hours later, only the cells that were grafted into the tail, or posterior of the embryo, integrated and differentiated into the correct cell layers, forming a chimaeric embryo—an organism with DNA of different origins. Because these cells seemed to prefer one part of the embryo, the researchers dubbed them region-selective.

Izpisua Belmonte suspects that embryos contain multiple types of pluripotent stem cells, including rsPSCs, during their early development. It is not yet clear whether the rsPSCs play a part in designating which part of the embryo will become the head or hind end. Identifying various types of pluripotent cells could allow researchers to study the early stages of human embryonic development by transplanting the stem cells into animal embryos.

Two for one
Izpisua Belmonte and his colleagues found that they could easily use DNA-cutting enzymes to edit the genomes of the region-selective stem cells, which is usually hard to do in pluripotent cells grown in vitro.

Gene editing could help scientists to optimize human cells’ ability to grow within another species, allowing the creation of transgenic chimaeras. Tesar says that the idea of using human pluripotent cells, such as rsPSCs, to create animals with human organs is not unrealistic, but he expects that it will be very difficult. For instance, it is unknown whether an animal’s developing immune system would recognize the human organ as part of the animal, or attack it. The signalling molecules that drive organ formation may differ between animals and humans, and a human organ might develop at a different rate from an animal organ.

Izpisua Belmonte acknowledges these concerns, adding that there may be ethical questions about creating viable human–animal hybrids. Although he says that his lab is already starting to implant pig embryos with a different type of stem cells, he says that the technique is only the very first step.

This article is reproduced with permission and was first published on May 6, 2015.

Sara Reardon is a freelance biomedical journalist based in Bozeman, Mont. She is a former staff reporter at Nature, New Scientist and Science and has a master’s degree in molecular biology.

More by Sara Reardon

First published in 1869, Nature is the world's leading multidisciplinary science journal. Nature publishes the finest peer-reviewed research that drives ground-breaking discovery, and is read by thought-leaders and decision-makers around the world.

More by Nature magazine

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe